Bethany Sensenig's most recent trade in KalVista Pharmaceuticals Inc was a trade of 45,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| KalVista Pharma Inc | Bethany L. Sensenig | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Jun 2026 | 45,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Alpha Cognition Inc | Bethany L. Sensenig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 6,991 | 6,991 | - | - | Common Share Options | |
| Alpha Cognition Inc | Bethany L. Sensenig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 5,489 | 5,489 | - | 0 | Common Shares | |
| Supernus Pharma Inc | Bethany L. Sensenig | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2026 | 4,475 | 0 | - | - | Restricted Stock Unit | |
| Supernus Pharma Inc | Bethany L. Sensenig | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2026 | 4,475 | 4,475 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharma Inc | Bethany L. Sensenig | Director | Sale of securities on an exchange or to another person at price $ 51.27 per share. | 19 Feb 2026 | 3,258 | 0 (0%) | 0% | 51.3 | 167,038 | Common Stock |
| Supernus Pharma Inc | Bethany L. Sensenig | Director | Sale of securities on an exchange or to another person at price $ 50.31 per share. | 19 Feb 2026 | 1,217 | 3,258 (0%) | 0% | 50.3 | 61,227 | Common Stock |
| Supernus Pharma Inc | Bethany L. Sensenig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2026 | 4,977 | 4,977 | - | - | Director Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Bethany L. Sensenig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2026 | 2,989 | 2,989 | - | - | Restricted Stock Unit | |
| KalVista Pharma Inc | Bethany L. Sensenig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Supernus Pharma Inc | Bethany Sensenig L. | Director | Sale of securities on an exchange or to another person at price $ 42.25 per share. | 14 Aug 2025 | 5,369 | 0 (0%) | 0% | 42.2 | 226,840 | Common Stock |
| Supernus Pharma Inc | Bethany Sensenig L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2025 | 5,369 | 5,369 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharma Inc | Bethany Sensenig L. | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2025 | 5,369 | 0 | - | - | Restricted Stock Units | |
| Supernus Pharma Inc | Bethany Sensenig L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 7,296 | 7,296 | - | - | Director Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Bethany Sensenig L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 4,475 | 4,475 | - | - | Restricted Stock Unit | |
| Supernus Pharma Inc | Bethany Sensenig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 8,252 | 8,252 | - | - | Director Stock Option (Right to Buy) | |
| Supernus Pharma Inc | Sensenig Bethany | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 5,369 | 5,369 | - | - | Restricted Stock Units | |
| Supernus Pharma Inc | Bethany Sensenig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2023 | 24,153 | 24,153 | - | - | Director Stock Option (Right to Buy) |